Literature DB >> 26806769

Drug-induced neurotoxicity in addiction medicine: From prevention to harm reduction.

S Mohammad Ahmadi Soleimani1, Hamed Ekhtiari2, Jean Lud Cadet3.   

Abstract

Neurotoxicity is considered as a major cause of neurodegenerative disorders. Most drugs of abuse have nonnegligible neurotoxic effects many of which are primarily mediated by several dopaminergic and glutamatergic neurotransmitter systems. Although many researchers have investigated the medical and cognitive consequences of drug abuse, the neurotoxicity induced by these drugs still requires comprehensive attention. The science of neurotoxicity promises to improve preventive and therapeutic strategies for brain disorders such as Alzheimer disease and Parkinson's disease. However, its clinical applications for addiction medicine remain to be defined adequately. This chapter reviews the most commonly discussed mechanisms underlying neurotoxicity induced by common drugs of abuse including amphetamines, cocaine, opiates, and alcohol. In addition, the known factors that trigger and/or predispose to drug-induced neurotoxicity are discussed. These factors include drug-related, individual-related, and environmental insults. Moreover, we introduce some of the potential pharmacological antineurotoxic interventions deduced from experimental animal studies. These interventions involve various targets such as dopaminergic system, mitochondria, cell death signaling, and NMDA receptors, among others. We conclude the chapter with a discussion of addicted patients who might benefit from such interventions.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction medicine; Drugs of abuse; Neuroprotection; Neurotoxicity

Mesh:

Substances:

Year:  2015        PMID: 26806769     DOI: 10.1016/bs.pbr.2015.07.004

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  16 in total

1.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

2.  Compulsive methamphetamine taking induces autophagic and apoptotic markers in the rat dorsal striatum.

Authors:  Rajeev Subu; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Arch Toxicol       Date:  2020-07-16       Impact factor: 5.153

Review 3.  Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective.

Authors:  Hamed Ekhtiari; Tara Rezapour; Robin L Aupperle; Martin P Paulus
Journal:  Prog Brain Res       Date:  2017-10-06       Impact factor: 2.453

Review 4.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

Review 5.  Emerging various environmental threats to brain and overview of surveillance system with zebrafish model.

Authors:  Rafael Vargas; Johny Ponce-Canchihuamán
Journal:  Toxicol Rep       Date:  2017-08-30

6.  Clinical Potential of an Enzyme-based Novel Therapy for Cocaine Overdose.

Authors:  Ting Zhang; Xirong Zheng; Ziyuan Zhou; Xiabin Chen; Zhenyu Jin; Jing Deng; Chang-Guo Zhan; Fang Zheng
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

7.  Measures of possible allostatic load in comorbid cocaine and alcohol use disorder: Brain white matter integrity, telomere length, and anti-saccade performance.

Authors:  Jonika Tannous; Benson Mwangi; Khader M Hasan; Ponnada A Narayana; Joel L Steinberg; Consuelo Walss-Bass; F Gerard Moeller; Joy M Schmitz; Scott D Lane
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

8.  Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes.

Authors:  Zixin Hu; Rong Jiao; Panpan Wang; Yun Zhu; Jinying Zhao; Phil De Jager; David A Bennett; Li Jin; Momiao Xiong
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

9.  NEuro COgnitive REhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial.

Authors:  Tara Rezapour; Javad Hatami; Ali Farhoudian; Mehmet Sofuoglu; Alireza Noroozi; Reza Daneshmand; Ahmadreza Samiei; Hamed Ekhtiari
Journal:  Basic Clin Neurosci       Date:  2015-10

10.  Neuro-protective effect of rutin against Cisplatin-induced neurotoxic rat model.

Authors:  Mashal M Almutairi; Wael A Alanazi; Musaad A Alshammari; Moureq Rashed Alotaibi; Ali R Alhoshani; Salim Salah Al-Rejaie; Mohamed M Hafez; Othman A Al-Shabanah
Journal:  BMC Complement Altern Med       Date:  2017-09-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.